These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6627129)

  • 1. Changes of catecholamines in central and peripheral tissues and in the urines of deoxycorticosterone--salt hypertensive rats.
    Buu NT; Kuchel O; Genest J
    Can J Physiol Pharmacol; 1983 Aug; 61(8):888-92. PubMed ID: 6627129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain catecholamines in spontaneously hypertensive and DOCA-salt hypertensive rats.
    Fujino K
    Acta Med Okayama; 1984 Aug; 38(4):325-40. PubMed ID: 6149670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal catecholamines and alpha 2-adrenergic receptors in salt-related and genetic hypertension.
    Dawson R; Oparil S
    Pharmacology; 1987; 34(2-3):131-42. PubMed ID: 3035585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central and peripheral adrenergic mechanisms in the development of deoxycorticosterone-saline hypertension in rats.
    Reid JL; Zivin JA; Kopin IJ
    Circ Res; 1975 Nov; 37(5):569-79. PubMed ID: 1192556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NaCl does not affect hypothalamic noradrenergic input in deoxycorticosterone acetate/NaCl and Dahl salt-sensitive rats.
    Chen YF; Meng QC; Wyss JM; Jin HK; Rogers CF; Oparil S
    Hypertension; 1990 Jul; 16(1):55-62. PubMed ID: 2365446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in urinary catecholamines of DOCA/saline hypertensive rats and the influence of environmental stress].
    Liu LS; Zhang X; Jin L
    Zhonghua Xin Xue Guan Bing Za Zhi; 1987 Aug; 15(4):228-30, 247-8. PubMed ID: 3440425
    [No Abstract]   [Full Text] [Related]  

  • 7. Catecholamines in discrete kidney regions. Changes in salt-sensitive Dahl hypertensive rats.
    Fernandez-Pardal J; Saavedra JM
    Hypertension; 1982; 4(6):821-6. PubMed ID: 6292085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential changes in urinary catecholamine in the transition from benign to malignant hypertension in rats.
    Sesoko S; Iwasawa H; Akema N; Matsukawa T; Sugiyama K; Shionoiri H; Kaneko Y
    Jpn Circ J; 1988 Feb; 52(2):197-202. PubMed ID: 3361705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of phenylethanolamine-N-methyltransferase: effects on brain catecholamine content and blood pressure in DOCA-salt hypertensive rats.
    Liang NY; Chandra A; Tessel RE; Grunewald GL; Borchardt RT
    Res Commun Chem Pathol Pharmacol; 1984 Dec; 46(3):319-29. PubMed ID: 6515125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in circulating levels and cardiovascular tissue content of neuropeptide Y-like immunoreactivity during the development of deoxycorticosterone acetate-salt hypertension in the rat.
    Moreau P; de Champlain J; Yamaguchi N
    J Hypertens; 1992 Aug; 10(8):773-80. PubMed ID: 1325509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central neural peptides and catecholamines in spontaneous and DOCA/salt hypertension.
    Morris M; Wren JA; Sundberg DK
    Peptides; 1981; 2(2):207-11. PubMed ID: 6117062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of presynaptic beta 2-adrenergic facilitation in the development and maintenance of DOCA-salt hypertension.
    Moreau P; Drolet G; Yamaguchi N; de Champlain J
    Am J Hypertens; 1993 Dec; 6(12):1016-24. PubMed ID: 7907884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosynthetic enzyme activities and catecholamines in adrenal glands of genetic and experimental hypertensive rats.
    Grobecker H; Saavedra JM; Weise VK
    Circ Res; 1982 May; 50(5):742-6. PubMed ID: 6122511
    [No Abstract]   [Full Text] [Related]  

  • 14. Blunted pressor responsiveness to quinpirole, a specific dopamine D2 receptor agonist, in conscious deoxycorticosterone acetate/NaCl hypertensive rats is related to atrial natriuretic peptide release.
    Chen YF; Jin HK; Paul R; Nagahama S
    J Pharmacol Exp Ther; 1988 Aug; 246(2):485-92. PubMed ID: 2969976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catecholamines in kidneys of normotensive and genetically hypertensive rats. Effects of salt load.
    Petrovic T; Bell C
    Hypertension; 1986 Feb; 8(2):122-7. PubMed ID: 3943889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain catecholamines during development of DOCA-salt hypertension in rats.
    Saavedra JM
    Brain Res; 1979 Dec; 179(1):121-7. PubMed ID: 509225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retardation of the development of hypertension in DOCA salt rats by taurine supplement.
    Inoue A; Takahashi H; Lee LC; Sasaki S; Kohno Y; Takeda K; Yoshimura M; Nakagawa M
    Cardiovasc Res; 1988 May; 22(5):351-8. PubMed ID: 3191519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlorthalidone alters the vascular reactivity of DOC-salt hypertensive rats to norepinephrine.
    Musso MN; Vasquez EC; Carvalhinho FB; Bissoli NS; Cabral AM
    Braz J Med Biol Res; 1990; 23(10):999-1003. PubMed ID: 2101067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced presynaptic beta 2-adrenergic facilitatory mechanism in conscious deoxycorticosterone acetate-salt hypertensive rats.
    Moreau P; de Champlain J; Yamaguchi N
    J Hypertens Suppl; 1991 Dec; 9(6):S68-9. PubMed ID: 1668014
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
    Li JS; Turgeon A; Schiffrin EL
    Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.